Novo Nordisk A/SNVONYSE
Loading
Total Costs & Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+17.9%
5Y CAGR+18.1%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+17.9%/yr
vs +12.1%/yr prior
5Y CAGR
+18.1%/yr
Consistent
Acceleration
+5.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
8 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $167.36B | +3.3% |
| 2024 | $162.06B | +25.0% |
| 2023 | $129.69B | +27.0% |
| 2022 | $102.14B | +24.3% |
| 2021 | $82.16B | +12.8% |
| 2020 | $72.82B | +4.7% |
| 2019 | $69.54B | +7.7% |
| 2018 | $64.58B | +3.0% |
| 2017 | $62.73B | -1.0% |
| 2016 | $63.35B | - |